UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $17.32, for a total value of $779,400.00. Following the completion of the sale, the chief executive officer owned 28,298,585 shares of the company’s stock, valued at approximately $490,131,492.20. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Daniel Dines also recently made the following trade(s):
- On Monday, January 5th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $15.73, for a total value of $707,850.00.
- On Friday, January 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.38, for a total value of $737,100.00.
- On Wednesday, December 31st, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.55, for a total transaction of $744,750.00.
- On Monday, December 29th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.44, for a total transaction of $739,800.00.
- On Friday, December 26th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.90, for a total value of $760,500.00.
- On Wednesday, December 24th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.91, for a total transaction of $760,950.00.
- On Monday, December 22nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.49, for a total transaction of $742,050.00.
- On Friday, December 19th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.07, for a total value of $723,150.00.
- On Wednesday, December 17th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.11, for a total value of $724,950.00.
- On Monday, December 15th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $17.30, for a total transaction of $778,500.00.
UiPath Stock Performance
UiPath stock traded up $0.48 during trading hours on Wednesday, hitting $17.81. 21,530,806 shares of the stock were exchanged, compared to its average volume of 28,870,660. The stock has a market capitalization of $9.52 billion, a P/E ratio of 42.39, a P/E/G ratio of 4.70 and a beta of 1.08. The business’s 50-day moving average is $15.58 and its two-hundred day moving average is $13.73. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $19.84.
Institutional Investors Weigh In On UiPath
Several large investors have recently made changes to their positions in PATH. Vanguard Group Inc. increased its holdings in UiPath by 4.9% during the third quarter. Vanguard Group Inc. now owns 47,895,884 shares of the company’s stock worth $640,847,000 after buying an additional 2,251,434 shares during the last quarter. TFG Asset Management GP Ltd grew its position in shares of UiPath by 53.3% in the 2nd quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company’s stock valued at $175,645,000 after acquiring an additional 4,772,244 shares during the period. AQR Capital Management LLC increased its stake in shares of UiPath by 76.0% during the 2nd quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company’s stock worth $145,732,000 after purchasing an additional 4,926,341 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of UiPath by 40.7% during the 2nd quarter. Federated Hermes Inc. now owns 8,048,321 shares of the company’s stock worth $103,019,000 after purchasing an additional 2,328,225 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of UiPath by 5.0% in the 2nd quarter. State Street Corp now owns 8,032,345 shares of the company’s stock valued at $102,814,000 after purchasing an additional 378,851 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on PATH. Cowen reiterated a “hold” rating on shares of UiPath in a report on Thursday, December 4th. BMO Capital Markets raised their price objective on UiPath from $13.00 to $17.00 and gave the stock a “market perform” rating in a research note on Thursday, December 4th. UBS Group reiterated a “neutral” rating on shares of UiPath in a report on Thursday, December 4th. Truist Financial set a $17.00 price target on UiPath in a report on Thursday, December 4th. Finally, Zacks Research raised UiPath from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $15.85.
View Our Latest Report on PATH
Key Stories Impacting UiPath
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: Inclusion/valuation check: Yahoo highlights UiPath’s potential S&P MidCap 400 inclusion and frames recent insider sales in the context of a broader valuation re-check — index inclusion would mechanically boost demand from passive funds and can support the stock. UiPath (PATH) Valuation Check After CEO Share Sales And S&P MidCap 400 Inclusion
- Positive Sentiment: Analyst/sector coverage is improving: Zacks and other outlet pieces list PATH among top robotics/AI and small-/mid-cap AI picks for 2026, reinforcing the growth/AI narrative that can attract thematic funds and multiple expansion. Top Robotics Stocks That Could Drive Impressive Returns in 2026
- Positive Sentiment: Product relevance: coverage (Diginomica) showing UiPath’s agentic AI being tested in regulated industries supports the company’s TAM and enterprise adoption story. That helps fundamentals-based investor interest. Evergen and UiPath show how agentic AI tests process discipline in regulated industries
- Positive Sentiment: Recent fundamentals: UiPath beat Q1/quarterly EPS and revenue expectations in December and showed ~16% revenue growth year-over-year — a concrete growth signal that underpins the bullish narrative (supports longer-term investor interest).
- Neutral Sentiment: Investor access: UiPath will present at the Needham Growth Conference (Jan 13); useful for management cadence and potential forward commentary but not a direct catalyst until new guidance or results are given. UiPath to Participate in the 28th Annual Needham Growth Conference
- Neutral Sentiment: Valuation debate: comparative pieces (AAII/Yahoo) discuss whether PATH is attractively priced after recent moves — useful framing but not an immediate trade catalyst. Which Is a Better Investment, Adeia Inc. or UiPath Inc. Stock?
- Negative Sentiment: Large insider sales: CFO Ashim Gupta sold 67,468 shares at ~$16.10 (~$1.09M) — a ~10.8% reduction in his holdings — and CEO Daniel Dines has repeatedly sold blocks of 45,000 shares; concentrated, visible insider selling tends to weigh on near-term sentiment. UiPath (NYSE:PATH) CFO Sells $1,086,234.80 in Stock
- Negative Sentiment: Analyst downgrade/target cut: RBC trimmed its PATH price target to $17 from $19, a sign of more cautious near-term expectations that can cap upside for traders. UiPath price target lowered to $17 from $19 at RBC Capital
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Further Reading
- Five stocks we like better than UiPath
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- You Still Think Silver’s a Joke? Watch What Happens Next.
- Punch these codes into your ordinary brokerage account
- This stock gets a 94 out of 100
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
